LIGAND PHARM Financial Diagnostics

LGNYZ -- USA Stock  

USD 0.0075  0.00  0.00%

Macroaxis technical analysis interface lets you check helpful technical drivers of LIGAND PHARM INC as well as the relationship between them. The company executives did not add any value to LIGAND PHARM INC investors in January. However, most investors can still diversify their portfolios with LIGAND PHARM INC to hedge your portfolio against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.0. The very small Stock volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about LIGAND PHARM as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis LIGAND PHARM price relationship with some important fundamental indicators such as market cap and management efficiency. Please see also Stocks Correlation.

LIGAND PHARM Note

The company had not issued any dividends in recent years.

LIGAND PHARM INC Alerts

LIGAND PHARM INC is not yet fully synchronised with the market data
LIGAND PHARM INC has some characteristics of a very speculative penny stock

LIGAND PHARM Technical and Predictive Indicators

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Piotroski F Score

Also Currentnly Active

Purchased over 40 shares of
over a week ago
Traded for 62.81
Purchased over 20 shares of
over a week ago
Traded for 140.38
Purchased over 20 shares of
over a week ago
Traded for 140.38
Please see also Stocks Correlation. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Search macroaxis.com